Item 9A. Controls and Procedures
Item
9A. Controls and Procedures.
Evaluation
of Disclosure Controls and Procedures
Disclosure
controls are procedures that are designed with the objective of ensuring that information required to be disclosed in HVII’s reports
filed under the Exchange Act, such as this Report, is recorded, processed, summarized and reported within the time period specified in
the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated
and communicated to HVII’s management, including the chief executive officer and chief financial officer, as appropriate to allow
timely decisions regarding required disclosure. HVII’s management evaluated, with the participation of the current chief executive
officer and chief financial officer (the “Certifying Officers”), the effectiveness of HVII’s disclosure controls and
procedures as of December 31, 2024, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, the Certifying Officers
concluded that, as of December 31, 2024, HVII’s disclosure controls and procedures were effective.
77
HVII
does not expect that its disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and
procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the
disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there
are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure
controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that HVII has detected all
its control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain
assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated
goals under all potential future conditions.
Management’s
Report on Internal Controls over Financial Reporting
This
Report on Form 10-K does not include a report of management’s assessment regarding internal control over financial reporting or
an attestation report of HVII’s independent registered public accounting firm due to a transition period established by rules of
the SEC for newly public companies.
Changes
in Internal Control over Financial Reporting
There
were no changes in HVII’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of
the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect,
HVII’s internal control over financial reporting.
Item
9B. Other Information.
(a)
None.
(b)
During the three months ended December 31, 2024, no director or “officer” (as defined in Rule 16a-1(f) under the Exchange
Act) of the Company informed the Company of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement”
or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K under the Exchange Act.
Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not
applicable.
PART
III
Item
10. Directors, Executive Officers and Corporate Governance. Directors and Executive Officers.
As
of the date of this Report, HVII’s directors and officers are as follows:
Name
Age
Title
Daniel
J. Hennessy
67
Chairman
of the Board of Directors and Chief Executive Officer
Thomas
D. Hennessy
40
President
and Chief Operating Officer and Director
Nicholas
Geeza
39
Executive
Vice President, Chief Financial Officer and Secretary
Grant
R. Allen
46
Independent
Director
Brian
Bonner
68
Independent
Director
Anna
Brunelle
57
Independent
Director
Javier
Saade
53
Independent
Director
Poonam
Sharma
47
Independent
Director
78
Daniel
J. Hennessy , HVII’s Chairman and Chief Executive Officer since its formation, is also a Managing Member of Hennessy Capital
Group LLC, an alternative investment firm he established in 2013 that focuses on sustainable industrial technology and infrastructure
sectors. Mr. Hennessy has also served as a director of Innventure, Inc. (NASDAQ: INV) since October 2024. Since September 2023, Mr. Hennessy
has served as the Chairman of the Board of Directors of Compass Digital Acquisition Corp. (NASDAQ: CDAQ). He also has served as Chairman
of the Board and CEO of Hennessy Capital Investment Corp. VI (NASDAQ: HCVI), or Hennessy VI, since January 2021. He also served as Chairman
of the Board and CEO of Hennessy Capital Investment Corp. V, or Hennessy V, from October 2020 until its liquidation in December 2022.
Mr. Hennessy served as Chairman of the Board and CEO of Hennessy Capital Acquisition Corp. IV, or Hennessy IV from March 2019 until its
business combination with Canoo Holdings Ltd, which closed on December 21, 2020 and is now known as Canoo Inc. (NASDAQ: GOEV). He also
served as a senior advisor to PropTech Investment Corporation II, a SPAC targeting businesses in the real estate technology industry,
and 7GC & Co. Holdings Inc., a SPAC targeting businesses in the technology industry. Mr. Hennessy previously served as senior advisor
to PropTech Acquisition Corporation, a SPAC targeting businesses in the real estate technology industry, which closed its initial business
combination with Porch Group Inc. (Nasdaq: PRCH) in December 2020. From January 2017 to October 2018, Mr. Hennessy served as Chairman
of the Board and Chief Executive Officer of Hennessy Capital Acquisition Corp. III, or Hennessy III, which merged with NRC Group Holdings,
LLC, a global provider of comprehensive environmental, compliance and waste management services, in October 2018, and in November 2019,
NRC Group Holdings Corp. merged with U.S. Ecology, Inc., and Mr. Hennessy served as a director of NRC Group Holdings Corp. from October
2018 to October 2019. From April 2015 to February 2017, Mr. Hennessy served as Chairman of the Board and CEO of Hennessy Capital Acquisition
Corp. II, or Hennessy II, which merged in February 2017 with Daseke, which was subsequently acquired in April 2024 by TFI International
(NYSE and TSX: TFII). Mr. Hennessy served as Vice Chairman of the Board of Daseke from February 2017 to June 2021. From September 2013
to February 2015, Mr. Hennessy served as Chairman of the Board and Chief Executive Officer of Hennessy Capital Acquisition Corp., or
Hennessy I, which merged with School Bus Holdings Inc. in February 2015 and is now known as Blue Bird Corporation (NASDAQ: BLBD), and
Mr. Hennessy served as Vice Chairman of the Board of Blue Bird Corporation from February 2015 to April 2019. Mr. Hennessy holds a B.A.
degree, magna cum laude, from Boston College and an M.B.A. from the University of Michigan Ross School of Business. Mr. Hennessy was
selected to serve as director due to his experience in private equity and public and private company board governance, as well as his
background in finance and his experience with Hennessy I, Hennessy II, Hennessy III, Hennessy IV, Hennessy V and Hennessy VI.
Thomas
D. Hennessy , the son of Mr. Daniel J. Hennessy and HVII’s President and Chief Operating Officer since HVII’s formation,
and a director since November 2024, is also a Managing Member of Hennessy Capital Group LLC, an alternative investment firm founded in
2013 that focuses on investing in industrial, infrastructure, real estate and sustainable technologies. Since August 2023, Mr. Hennessy
has served as Chief Executive Officer and as a director of Compass Digital Acquisition Corp. (Nasdaq: CDAQ), a SPAC, which in September
2024 entered and announced a definitive business combination agreement with EEW Renewables Ltd., a proven developer of utility-scale
renewable energy projects across Europe and Australia. Previously, amongst other roles, Mr. Hennessy served as: (i) Chairman of the Board
and Chief Executive Officer of Global Technology Acquisition Corp. I (a SPAC that liquidated its trust account and delisted its securities
from Nasdaq in October 2024) since April 2024; (ii) Director of TortoiseEcofin Acquisition Corp. III from August 2023 until its liquidation
in September 2024; (iii) Chairman of the Board and Chief Executive Officer of two, a SPAC, which in March 2024 closed a business combination
agreement with LatAm Logistic Properties S.A. (NYSE: LPA), a leading developer, owner and manager of institutional quality, class A industrial
and logistics real estate in Central and South America; (iv) Director of Jaguar Global Growth Corporation I, a SPAC, which in October
2023 closed a business combination with Captivision Inc. (Nasdaq: CAPT), a leading designer and manufacturer of architectural media display
glass; (v) Director of 7GC & Co. Holdings Inc., a SPAC, which in December 2023 closed a business combination with Banzai International,
Inc. (Nasdaq: BNZI), a leading marketing technology company that provides data-driven marketing and sales solutions; (vi) Chairman of
the Board and Co-Chief Executive Officer of PropTech Investment Corporation II, a SPAC, which in November 2022 closed a business
combination with Appreciate Holdings, Inc.; and (vii) Chairman of the Board and Co-Chief Executive Officer of PropTech Acquisition Corporation,
a SPAC, which in December 2020, closed a business combination with Porch Group Inc. (Nasdaq: PRCH) and subsequently served as an independent
director of Porch Group Inc. Mr. Hennessy previously served as a Portfolio Manager of Abu Dhabi Investment Authority (ADIA). Mr. Hennessy
holds a B.A. degree from Georgetown University and an MBA from the University of Chicago Booth School of Business. Mr. Hennessy was selected
to serve as director due to his experience in private equity and public and private company board governance, as well as his background
in finance and his experience with Compass Digital Acquisition Corp., Global Technology Acquisition Corp. I, TortoiseEcofin Acquisition
Corp. III, two, Jaguar Global Growth Corporation I, 7GC & Co. Holdings Inc., PropTech Investment Corporation II and PropTech Acquisition
Corporation.
79
Nicholas
Geeza , HVII’s Executive Vice President, Chief Financial Officer and Secretary since HVII’s formation, has served since
August 2024 as Executive Vice President, Chief Financial Officer and Secretary of Hennessy Capital Investment Corp. VI (NASDAQ: HCVI),
a SPAC, since April 2023, as Head of Business Development of Hennessy Capital Growth Strategies, an alternative investment company, since
April 2023, and as Chief Financial Officer of Compass Digital Acquisition Corp (NASDAQ: CDAQ), a SPAC, since August 2023 and since April
2024, as Chief Financial Officer of Global Technology Acquisition Corp. I, a SPAC that liquidated its trust account and delisted its
securities from Nasdaq in October 2024.
Mr.
Geeza previously served as Chief Financial Officer of two (NYSE: TWOA), a SPAC, from May 2023 to March 2024, and as Enterprise Sales
Director for Capital Preferences, Ltd., a wealth technology platform focused on using behavioral economics to reveal client preferences
and drive increased assets under management for global enterprise financial institutions, from March 2022 to April 2023. From November
2007 to March 2022, Mr. Geeza served as Senior Vice President in the Derivative Products Group at U.S. Bank National Association, where
he was responsible for developing and servicing client relationships in the National Corporate Banking Technology, Automotive and Insurance
divisions. During his tenure, Mr. Geeza assisted in the development and successful implementation of a dynamic hedging platform, advised
on compliance with U.S. GAAP accounting requirements and negotiated International Swaps and Derivatives Association, Dodd-Frank and collateral
management documentation. Prior to U.S. Bank, Mr. Geeza worked at JP Morgan Chase & Co. in New York. Mr. Geeza graduated Cum Laude
with a B.S. from Georgetown University and earned an MBA from the University of Chicago Booth School of Business.
Grant
R. Allen has served as a member of HVII’s board of directors since HVII’s initial public offering. Mr. Allen has served
as a Venture Partner of Giant Ventures since May 2024. Mr. Allen previously served as founding General Partner from August 2019 to January
2024 at SE Ventures, a financially oriented, single LP fund created in partnership with Schneider Electric. Prior to SE Ventures, Mr.
Allen served as global head of venture investing at Zurich-based ABB Ltd. where he was also a member of ABB’s Technology Leadership
Team and served on the Board of Directors of Enbala Power Networks, acquired in 2020 by Generac, and Industrial Defender, acquired by
Lockheed Martin in 2014. Prior to joining ABB in 2010, Mr. Allen worked at Core Capital Partners, Microsoft Corporation, Dean & Company
and Bates White. Mr. Allen graduated cum laude from Duke University’s Pratt School of Engineering with a BSE in Civil and Environmental
Engineering and received his MBA from The Wharton School of the University of Pennsylvania. Mr. Allen was selected to serve as director
due to his extensive experience investing and venture capital background.
Brian
Bonner has served as a member of HVII’s board of directors since HVII’s initial public offering and chairs HVII’s
compensation committee. Mr. Bonner served on Board of Directors of Daseke from February 2015 to April 2024, including roles as Executive
Chairman (August 2019 until August 2020), Independent Chairman of the Board of Directors of Daseke (August 2020 until June 2022) and
Chair of the Compensation Committee of the Board of Directors of Daseke (January 2020 until July 2022) and the Audit and Compensation
Committees of the Board of Directors of Daseke. Mr. Bonner’s 33-year career with Texas Instruments, Inc. (NASDAQ: TXN), a Fortune
500 publicly traded technology company that designs and manufactures semiconductors and various integrated circuits, spanned several
executive leadership positions, including Vice President and Chief Information Officer from 2000 to 2014 and other leadership positions
in product profit and loss management, worldwide marketing, and post-acquisition integration. Mr. Bonner served as a member on the Board
of Directors of Copper Mobile from 2012 to 2015 and as an advisory board member for Gemini Israel Funds from June 2004 to May 2015. He
holds an MBA in Marketing and Finance from the Fuqua School of Business at Duke University, an MSEE and BSEE from the University of Michigan,
and a BA in Physics from Kalamazoo College. Mr. Bonner was selected to serve as director due to his experience and insight in sales management;
human capital management, organization and compensation; corporate oversight and governance; business performance; business scaling post-acquisition
implementation/integration; information technology management and development; and cybersecurity and information technology systems.
80
Anna
Brunelle has served as a member of HVII’s board of directors since HVII’s initial public offering. Ms. Brunelle has served
as Chief Financial Officer of May Mobility, an autonomous driving company, since October 2023 and as an Independent Director of Hennessy
Capital Investment Corp. VI since October 2021 and Compass Digital Acquisition Corp. since September 2023. Previously, Ms. Brunelle served
as Chief Financial Officer of Ouster Inc. from August 2020 to May 2023, which completed a business combination with Colonnade Acquisition
Corp., a SPAC, in March 2021, which subsequently merged with Velodyne Lidar, Inc. (previously NASDAQ: VLDR) in February 2023. She previously
served as Chief Financial Officer of Kinestral Technologies from April 2018 through May 2020 and Chief Financial Officer and Interim
Chief Operating Officer of Soylent from March 2016 through October 2017. She has also served as Chief Financial Officer of GlobalLogic,
Chief Financial Officer of Tivo, Inc. and Senior Consultant for Deloitte & Touche, LLP. Ms. Brunelle currently serves as a director
of Compass Digital Acquisition Corp. (NASDAQ: CDAQ) and as a director of Bolt Threads, Inc. and previously served as a director of Halio
International from March 2019 through May 2020. During her tenure in leadership positions, she has worked on successful IPOs of technology
companies and completed multiple private and public acquisitions and divestitures. Ms. Brunelle received her B.S. in Business Administration
(accounting concentration) from California Polytechnic State University — San Luis Obispo. Ms. Brunelle was selected to serve as
a director due to her background in accounting and finance and her experience as the chief financial officer for both public and private
companies and as a director.
Javier
Saade has served as a member of HVII’s board of directors since HVII’s initial public offering. Mr. Saade is Founder
& Managing Partner of Impact Master Holdings since 2019, Venture Partner at Fenway Summer since 2016, and Operating Partner at Presidio
Investors since 2023. He also serves as Chairman of the Board of Directors of GP Funding, Inc. (private-equity-owned financial services
company) since 2019, Chairman of the Board of Directors of The Only Agency (private equity-owned media & entertainment company) since
2024, Member of the Board of Directors of VCheck Global Holdings (private-equity-owned tech services company) since 2024, Member of the
Board of Trustees of Swedish Providence (a large health services enterprise), Member of the Board of Advisors of Harvard University’s
Arthur Rock Center for Entrepreneurship, Executive Fellow at Harvard Business School, Lecturer at University of Washington’s Foster
School of Business, CNBC Contributor and host of “Top Of The Game”. Mr. Saade Javier served as Audit Committee Chair of the
Board of Directors of SoftBank Vision Fund Investment Corp. (NASDAQ: SVFA) from January 2021 to March 2023, Lead Independent Director
and Nominations & Governance Committee Chair of the Board of Directors of Porch Group, Inc. (NASDAQ: PRCH) December 2020 to March
2022, Board Member of Global Technology Acquisition Corp. (NASDAQ: GTAC) from 2023 to 2024, Board Member of two inc. from 2023 to 2024,
now Logistics Properties of the Americas (NYSE: LPA), Member of the Boards of Trustees of The Nature Conservancy and Pan American Development
Foundation and Member of the Board of Advisors of DocuSign, Inc. (NASDAQ: DOCU). In 2013, he was appointed by the White House to serve
as Associate Administrator, Chief of Investment & Innovation of the U.S. Small Business Administration (SBA), concurrently served
on the Committee for Small and Emerging Companies at the U.S. Securities & Exchange Commission (SEC) and subsequently served on the
Presidential Transition at the Department of Treasury and the White House’s Advisory Committee for Trade Policy and Negotiations.
Prior to public service he spent over 20 years in investing, entrepreneurial, operating and advisory roles at McKinsey & Company,
Booz Allen & Hamilton (NYSE: BAH), Bridgewater Associates, Abbott Laboratories (NYSE: ABT) and Air America, a company he co-founded.
He holds an MBA from Harvard Business School, an MS in Operations & Technology from Illinois Institute of Technology and a BS in
Industrial Management from Purdue University. Mr. Saade was selected to serve as a director of the Company due to his extensive operating,
entrepreneurial, strategy, capital allocation and governance experience with public and private companies.
Poonam
Sharma has served as a member of HVII’s board of directors since HVII’s initial public offering and chairs HVII’s
audit committee. Ms. Sharma has served as an Investment Committee Advisor of Healthy Home Innovation Fund since March 2024 and as an
Independent Director of Lumen Energy since January 2024. Ms. Sharma previously served as an Independent Director of Fifth Wall Acquisition
Corp. III from May 2021 to December 2023, which completed its business combination with Mobile Infrastructure Corporation (NYSE American:
BEEP). Ms. Sharma is also a serial entrepreneur, real estate industry veteran and public speaker with a passion for innovating around
the built world. Most recently CEO of Raise, she aimed to revolutionize childcare for the future of work. Previously, she founded StealthForce,
(the gig economy of real estate; a resource and project management platform for CRE), which was exited in early 2019. Prior to StealthForce,
she was Deputy to the Head of Global Real Estate Asset Management at Partners Group AG ($40 billion AUM), and earlier employee 13 at
The Gerson Lehrman Group, which was the world’s first institutional expert network. Ms. Sharma earned her Bachelor of Arts at Harvard
and Master of Business Administration at Wharton, and spent over a decade in real estate development and investment. Ms. Sharma was selected
to serve as a director due to her past leadership experience.
81
Number
and Terms of Office of Officers and Directors
HVII’s
board of directors consists of seven members. Holders of HVII’s founder shares have the right to elect all of its directors or
remove any one of them for any reason prior to consummation of HVII’s initial business combination, and holders of its public shares
will not have the right to vote on the appointment or removal of directors during such time. These provisions of HVII’s amended
and restated memorandum and articles of association may only be amended if approved by a majority of at least 90% of its ordinary shares
voting at a general meeting. HVII may not hold an annual meeting of shareholders until after it consummates its initial business combination.
In accordance with Nasdaq corporate governance requirements, HVII is not required to hold an annual meeting until one year after its
first fiscal year end following its listing on Nasdaq. Subject to any other special rights applicable to the shareholders, any vacancies
on HVII’s board of directors may be filled by the vote of the remaining directors then in office.
HVII’s
officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms
of office. HVII’s board of directors is authorized to appoint persons to the offices set forth in its amended and restated memorandum
and articles of association as it deems appropriate. HVII’s amended and restated memorandum and articles of association provides
that its officers may consist of a Chief Executive Officer, a President, a Chief Financial Officer, Vice Presidents, a Secretary, Assistant
Secretaries, a Treasurer, Assistant Treasurers and such other offices as may be determined by the board of directors.
Director
Independence
Nasdaq
listing standards require that a majority of HVII’s board of directors be independent. An “independent director” is
defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship
which, in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment
in carrying out the responsibilities of a director. As of the date of this Report, HVII has determined that directors Mr. Allen, Mr.
Bonner, Ms. Brunelle, Mr. Saade and Ms. Sharma are “independent directors” as defined in Nasdaq listing standards and applicable
SEC rules. The audit committee of HVII is entirely composed of independent directors meeting Nasdaq’s additional requirements applicable
to members of the audit committee. The independent directors of HVII have regularly scheduled meetings at which only independent directors
are present.
Committees
of the Board of Directors
HVII’s
board of directors has two standing committees: an audit committee and a compensation committee. Subject to phase-in rules and a limited
exception, Nasdaq rules and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of
independent directors, and Nasdaq rules require that the compensation committee of a listed company be comprised solely of independent
directors. Each committee operates under a charter that has been approved by HVII’s board of directors and has the composition
and responsibilities described below. The charter of each committee is available on HVII’s website.
Audit
Committee
HVII
has established an audit committee of the board of directors. The members of HVII’s audit committee are Ms. Sharma, Mr. Bonner
and Ms. Brunelle, with Ms. Sharma chairing the audit committee. Under Nasdaq listing standards and applicable SEC rules, HVII is required
to have at least three members on the audit committee, all of whom must be independent. Each of Ms. Sharma, Mr. Bonner and Ms. Brunelle
meets the independent director standard under Nasdaq listing standards and under Rule 10-A-3(b)(1) of the Exchange Act.
Each
member of the audit committee is financially literate, and HVII’s board of directors has determined that Ms. Sharma qualifies as
an “audit committee financial expert” as defined in applicable SEC rules and has accounting or related financial management
expertise.
82
HVII
has adopted an audit committee charter, which details the purpose and principal functions of the audit committee, including:
●
assisting
board oversight of (1) the integrity of HVII’s financial statements, (2) HVII’s compliance with legal and regulatory
requirements, (3) HVII’s independent registered public accounting firm’s qualifications and independence and (4) the
performance of HVII’s internal audit function and independent registered public accounting firm;
●
reviewing
the appointment, compensation, retention, replacement and oversight of the work of the independent registered public accounting firm
and any other independent registered public accounting firm engaged by HVII;
●
pre-approving
all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered public
accounting firm engaged by HVII, and establishing pre-approval policies and procedures;
●
reviewing
and discussing with the independent registered public accounting firm all relationships the auditors have with HVII in order to evaluate
their continued independence;
●
setting
clear hiring policies for employees or former employees of the independent registered public accounting firm;
●
setting
clear policies for audit partner rotation in compliance with applicable laws and regulations;
●
obtaining
and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent
registered public accounting firm’s internal quality-control procedures and (2) any material issues raised by the most recent
internal quality-control review, or peer review, of the independent registered public accounting firm, or by any inquiry or investigation
by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out
by the firm and any steps taken to deal with such issues;
●
meeting
to review and discuss HVII’s annual audited financial statements and quarterly financial statements with management and the
independent registered public accounting firm, including reviewing HVII’s specific disclosures under “Management’s
Discussion and Analysis of Financial Condition and Results of Operations”;
●
reviewing
and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC
prior to HVII entering into such transaction; and
●
reviewing
with management, the independent registered public accounting firm, and HVII’s legal advisors, as appropriate, any legal, regulatory
or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published
reports that raise material issues regarding HVII’s financial statements or accounting policies and any significant changes
in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.
Compensation
Committee
HVII
has established a compensation committee of the board of directors. The members of HVII’s compensation committee are Mr. Bonner,
Mr. Allen and Mr. Saade, with Mr. Bonner chairing the compensation committee. Under Nasdaq listing standards and applicable SEC rules,
HVII is required to have at least two members on the compensation committee, all of whom must be independent. Each of Mr. Bonner, Mr.
Allen and Mr. Saade are independent.
83
HVII
has adopted a compensation committee charter, which details the purpose and responsibility of the compensation committee, including:
●
reviewing
and approving on an annual basis the corporate goals and objectives relevant to HVII’s Chief Executive Officer’s compensation,
evaluating HVII’s Chief Executive Officer’s performance in light of such goals and objectives and determining and approving
the remuneration (if any) of HVII’s Chief Executive Officer based on such evaluation;
●
reviewing
and making recommendations to HVII’s board of directors with respect to (or approving, if such authority is so delegated by
HVII’s board of directors) the compensation, and any incentive-compensation and equity-based plans that are subject to board
approval of all of HVII’s other officers;
●
reviewing
HVII’s executive compensation policies and plans;
●
implementing
and administering HVII’s incentive compensation equity-based remuneration plans;
●
assisting
management in complying with HVII’s proxy statement and annual report disclosure requirements;
●
approving
all special perquisites, special cash payments and other special compensation and benefit arrangements for HVII’s officers
and service providers;
●
producing
a report on executive compensation to be included in HVII’s annual proxy statement; and
●
reviewing,
evaluating and recommending changes, if appropriate, to the remuneration for directors.
The
charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant,
independent legal counsel or other adviser and is directly responsible for the appointment, compensation and oversight of the work of
any such adviser.
However,
before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee
will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.
Director
Nominations
HVII
does not have a standing nominating committee, though it intends to form a corporate governance and nominating committee as and when
required to do so by law or Nasdaq rules. In accordance with Rule 5605 of the Nasdaq rules, a majority of the independent directors may
recommend a director nominee for selection by the board of directors. The board of directors believes that the independent directors
can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing
nominating committee. The directors who will participate in the consideration and recommendation of director nominees are Mr. Allen,
Mr. Bonner, Ms. Brunelle, Mr. Saade and Ms. Sharma. In accordance with Rule 5605 of the Nasdaq rules, all such directors are independent.
As there is no standing nominating committee, HVII does not have a nominating committee charter in place.
HVII
has not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess.
In general, in identifying and evaluating nominees for director, the board of directors considers educational background, diversity of
professional experience, knowledge of HVII’s business, integrity, professional reputation, independence, wisdom and the ability
to represent the best interests of its shareholders. Prior to HVII’s initial business combination, holders of its public shares
will not have the right to recommend director candidates for nomination to the board of directors.
Code
of Ethics
HVII
has adopted a Code of Ethics applicable to its directors, officers and service providers. HVII has filed a copy of its Code of Ethics
and its audit and compensation committee charters as exhibits to its registration statement on Form S-1 (File No. 333-283087) filed in
connection with its initial public offering.
84
Investors
may review these documents by accessing HVII’s public filings at the SEC’s website at www.sec.gov. In addition, a copy of
the Code of Ethics will be provided without charge upon request from HVII. HVII intends to disclose any amendments to or waivers of certain
provisions of its Code of Ethics in a Current Report on Form 8-K.
Insider
Trading Policy
HVII
has adopted an insider trading policy governing the purchase, sale and/or other dispositions of HVII’s securities by directors,
officers and employees or HVII itself, which is reasonably designed to promote compliance with insider trading laws, rules and regulations
and applicable listing standards (the “Insider Trading Policy”).
The
foregoing description of the Insider Trading Policy does not purport to be complete and is qualified in its entirety by the terms and
conditions of the Insider Trading Policy, a copy of which is filed with this Report as Exhibit 19.1 and is incorporated herein by reference.
Item
11. Executive Compensation.
Executive
Officer and Director Compensation
As
of the date of HVII’s initial public offering, none of HVII’s officers or directors received any compensation for services
rendered to it. HVII’s sponsor, officers, directors and their respective affiliates are reimbursed for any out-of-pocket expenses
incurred in connection with activities on HVII’s behalf such as identifying potential target businesses and performing due diligence
on suitable business combinations. In addition, commencing on the date on which HVII’s securities were first listed on Nasdaq,
HVII pays an amount equal to $15,000 per month to an affiliate of its sponsor for office space, utilities and secretarial and administrative
support, and HVII pays Nicholas Geeza, its Chief Financial Officer, $10,000 per month for his services until the earlier of the consummation
of HVII’s initial business combination or its liquidation. Each of Mr. Allen, Mr. Bonner, Ms. Brunelle and Mr. Saade received 25,000
founder shares for his or her service as a director and Ms. Sharma received 30,000 founder shares for her service as a director. HVII’s
audit committee reviews on a quarterly basis all payments that were made by it to its sponsor, officers, directors or any of their respective
affiliates.
After
the completion of HVII’s initial business combination, directors or members of its management team who remain with HVII may be
paid consulting, management or other compensation from the combined company. All compensation will be fully disclosed to shareholders,
to the extent then known, in the tender offer materials or proxy solicitation materials furnished to HVII’s shareholders in connection
with a proposed business combination. It is unlikely the amount of such compensation will be known at the time, because the directors
of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation to
be paid to HVII’s officers after the completion of its initial business combination will be determined by a compensation committee
constituted solely by independent directors.
HVII
is not party to any agreements with its executive officers and directors that provide for benefits upon termination of providing services
to it. The existence or terms of any such employment, independent contractor or service provider arrangements may influence HVII’s
management’s motivation in identifying or selecting a target business, and HVII does not believe that the ability of its management
to remain with it after the consummation of its initial business combination should be a determining factor in its decision to proceed
with any potential business combination.
Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The
following table sets forth information regarding the beneficial ownership of HVII’s ordinary shares as of March 28, 2025, based
on information obtained from the persons named below, with respect to the beneficial ownership of shares of HVII’s ordinary shares,
by:
●
each
person known by HVII to be the beneficial owner of more than 5% of HVII’s outstanding ordinary shares;
●
each
of HVII’s executive officers and directors; and
●
all
of HVII’s executive officers and directors as a group.
85
Unless
otherwise indicated, HVII believes that all persons named in the table have sole voting and investment power with respect to all ordinary
shares beneficially owned by them. The following table does not reflect record or beneficial ownership of the share rights as these rights are not exercisable
within 60 days of this Report.
Class
A Ordinary Shares
Class
B Ordinary Shares
Name
and Address of Beneficial Owner (1)
Number
of Class A Ordinary Shares Beneficially Owned
Percentage
of Class A Ordinary Shares
Number
of Class B Ordinary Shares Beneficially Owned(2)
Percentage
of Class B Ordinary Shares
HC
VII Sponsor LLC (HVII’s sponsor)(3)
500,000
2 %
5,203,333
78 %
Daniel
J. Hennessy (3)
500,000
2 %
5,203,333
78 %
Thomas
D. Hennessy (3)(4)
500,000
2 %
5,953,333
89 %
Nicholas
Geeza
—
—
250,000
4 %
Grant
R. Allen (5)
—
—
25,000
*
Brian
Bonner (5)
—
—
25,000
*
Anna
Brunelle (5)
—
—
25,000
*
Javier
Saade (5)
—
—
25,000
*
Poonam
Sharma (5)
—
—
30,000
*
All
directors and executive officers and directors as a group (8 individuals)
500,000
2 %
6,333,333
100 %
These
shareholders known to HVII to beneficially own more than 5 percent of HVII’s outstanding ordinary shares as of March 28, 2025
are:
The
K2 Principal Fund, L.P. (6)
1,700,000
8.6 %
—
—
Linden
Advisors LP (7)
1,213,732
6.2 %
—
—
Tenor
Capital Management Company, L.P. (8)
1,500,000
7.6 %
—
—
*
Less than 1%
(1)
Unless
otherwise noted, the business address of each of the following entities or individuals is c/o Hennessy Capital Investment Corp. VII,
195 US Hwy 50, Suite 309, Zephyr Cove, Nevada 89448.
(2)
Interests
shown consist solely of Class B ordinary shares which are referred to herein as founder shares. Such shares will automatically convert
into Class A ordinary shares at the time of HVII’s initial business combination, or at any time prior thereto at the option of the holder
thereof, on a one-for-one basis, subject to adjustment, as described herein.
(3)
HC
VII Sponsor LLC is the record holder of the shares reported herein. Hennessy Capital Group LLC is the sole manager of HVII’s
sponsor. Daniel J. Hennessy, HVII’s Chairman and Chief Executive Officer, and Thomas D. Hennessy, HVII’s President, Chief
Operating Officer and a director, are the sole managing members of Hennessy Capital Group LLC. Consequently, each of Mr. Daniel Hennessy
and Mr. Thomas Hennessy may be deemed the beneficial owner of securities held by HVII’s sponsor and have shared voting and
dispositive control over such securities. Each of Mr. Daniel Hennessy and Mr. Thomas Hennessy disclaims beneficial ownership over
any securities owned by HVII’s sponsor in which he does not have any pecuniary interest.
(4)
Mr.
Thomas D. Hennessy is the record holder of 750,000 of the Class B ordinary shares reported herein.
(5)
Does
not include any shares indirectly owned by this individual as a result of his or her direct or indirect ownership interest in HVII’s
sponsor.
(6)
This
information is based solely on a Schedule 13G filed on January 21, 2025 jointly by Shawn Kimel Investments, Inc., an Ontario corporation
(“SKI”), The K2 Principal Fund, L.P., an Ontario limited partnership (the “Fund”), K2 Genpar 2017 Inc., an
Ontario corporation and the General Partner to the Fund (“Genpar 2017”), and K2 & Associates Investment Management
Inc., an Ontario corporation (“K2 & Associates”). Together, SKI, the Fund, Genpar2017, and K2 & Associates are
the “K2 Reporting Persons”. Mr. Kimel is President of SKI. Mr. Sikorski is Secretary of Genpar 2017, and President of
K2 & Associates. K2 & Associates is a direct 66.5% owned subsidiary of SKI, and is the investment manager of the Fund. The
K2 Reporting Persons have shared voting power and shared dispositive power of 1,700,000 shares. The principal business address of
the K2 Reporting Persons is 2 Bloor St West, Suite 801, Toronto, Ontario, M4W 3E2.
86
(7)
This
information is based solely on a Schedule 13G filed on January 23, 2025 jointly by Linden Capital L.P., a Bermuda limited partnership
(“Linden Capital”), Linden GP LLC, a Delaware limited liability company (“Linden GP”), Linden Advisors LP,
a Delaware limited partnership (“Linden Advisors”), and Siu Min (Joe) Wong (“Mr. Wong”). Together, Linden
Capital, Linden GP, Linden Advisors, and Mr. Wong are the “Linden Reporting Persons.” Linden GP is the general partner
of Linden Capital and, in such capacity, may be deemed to beneficially own the shares held by Linden Capital. Linden Advisors is
the investment manager of Linden Capital and trading advisor or investment advisor for the managed accounts. Mr. Wong is the principal
owner and controlling person of Linden Advisors and Linden GP. In such capacities, Linden Advisors and Mr. Wong may each be deemed
to beneficially own the shares held by each of Linden Capital and the managed accounts. Linden Advisors and Mr. Wong have shared
voting power and shared dispositive power of 1,213,732 shares. The principal business address for Linden Capital is Victoria Place,
31 Victoria Street, Hamilton HM10, Bermuda. The principal business address for each of Linden Advisors, Linden GP and Mr. Wong is
590 Madison Avenue, 32nd Floor, New York, New York 10022.
(8)
This
information is based solely on a Schedule 13G filed on January 24, 2025 jointly by Tenor Capital Management Company, L.P, Tenor Opportunity
Master Fund, Ltd and Robin Shah (together, the “Tenor Reporting Persons”). The Tenor Reporting Persons have shared voting
power and dispositive power of 1,500,000 shares. The principal business address of the Tenor Reporting Persons is 810 Seventh Avenue,
Suite 1905, New York, New York 10019.
Item
13. Certain Relationships and Related Transactions, and Director Independence.
Certain
Relationships and Related Transactions
On
October 8, 2024, HVII’s sponsor purchased an aggregate of 5,750,000 Class B ordinary shares (“founder shares”) for
an aggregate purchase price of $25,000, or approximately $0.004 per share. On January 10, 2025, the Company issued an additional 958,333
founder shares for no additional consideration, resulting in the sponsor holding a total of 6,708,333 founder shares. The number of founder
shares issued was determined based on the expectation that the founder shares would represent 25% of the outstanding ordinary shares
upon completion of HVII’s initial public offering. In December 2024, HVII’s sponsor transferred 250,000 founder shares to
Nicholas Geeza, HVII’s Executive Vice President, Chief Financial Officer and Secretary, and an aggregate of 130,000 founder shares
to its independent directors. In January 2025, HVII’s sponsor transferred 750,000 founder shares to Thomas D. Hennessy, HVII’s
President and Chief Operating Officer.
HVII’s
sponsor and the underwriters purchased an aggregate of 690,000 private placement units for a purchase price of $10.00 per private placement
unit in the private placement, for a total of $6,900,000. Of the 690,000 private placement units, 500,000 private placement units were
purchased by HVII’s sponsor, and an aggregate of 190,000 private placement units were purchased by the underwriters. The private
placement units (including the securities underlying such private placement units) may not, subject to certain limited exceptions, be
transferred, assigned or sold by HVII’s sponsor or the underwriters until 30 days after the completion of HVII’s initial
business combination.
If
any of HVII’s officers or directors becomes aware of a business combination opportunity which is suitable for one or more entities
to which he or she has fiduciary, contractual or other obligations or duties, he or she will honor these obligations and duties to present
such business combination opportunity to such entities first, and only present it to HVII if such entities reject the opportunity and
he or she determines to present the opportunity to us. HVII’s officers and directors currently have other relevant fiduciary, contractual
or other obligations or duties that may take priority over their duties to HVII.
87
HVII’s
sponsor, officers and directors or any of their respective affiliates are reimbursed for any out-of-pocket expenses incurred in connection
with activities on HVII’s behalf such as identifying potential target businesses and performing due diligence on suitable business
combinations. HVII’s audit committee reviews on a quarterly basis all payments that were made by HVII to its sponsor, officers,
directors or HVII’s or any of their respective affiliates and determines which expenses and the amount of expenses that will be
reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities
on HVII’s behalf.
HVII’s
sponsor agreed to loan HVII of up to $250,000 to be used for a portion of the expenses of HVII’s initial pubic offering. The loan
was non-interest bearing, unsecured and due at the earlier of March 31, 2025 or the closing of HVII’s initial public offering.
As of December 31, 2024, HVII had borrowed $76,790 under the note. On January 21, 2025, HVII repaid the total outstanding balance of
the note amounting to $109,994. Borrowings under the note are no longer available.
HVII
pays an amount equal to $15,000 per month to an affiliate of its sponsor for office space, utilities and secretarial and administrative
support. Upon completion of HVII’s initial business combination or its liquidation, it will cease paying these monthly fees. Accordingly,
in the event the consummation of HVII’s initial business combination takes the maximum 24 months, its sponsor’s affiliates
will be paid a total of $360,000 ($15,000 per month in either case) and will be entitled to be reimbursed for any out-of-pocket expenses.
HVII
pays Nicholas Geeza, its Chief Financial Officer, $10,000 per month for his services until the earlier of the consummation of HVII’s
initial business combination or its liquidation.
In
addition, in order to finance transaction costs in connection with an initial business combination, HVII’s sponsor, an affiliate
of HVII’s sponsor or HVII’s officers and directors may, but none of them is obligated to, loan HVII funds as may be required.
If HVII completes its initial business combination, HVII would repay such loaned amounts out of the proceeds of the trust account released
to HVII. In the event that HVII’s initial business combination does not close, it may use a portion of the working capital held
outside the trust account to repay such loaned amounts but no proceeds from HVII’s trust account would be used for such repayment.
Up to $2.5 million of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the
option of the lender. The private placement units would be identical to the private placement units issued to HVII’s sponsor. Except
for the foregoing, the terms of such loans by HVII’s sponsor, an affiliate of HVII’s sponsor or HVII’s officers and
directors, if any, have not been determined and no written agreements exist with respect to such loans. HVII does not expect to seek
loans from parties other than its sponsor, an affiliate of HVII’s sponsor or HVII’s officers and directors, if any, as HVII
does not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds
in HVII’s trust account.
After
HVII’s initial business combination, members of its management team who remain with HVII, if any, may be paid consulting, management
or other fees from the combined company with any and all amounts being fully disclosed to HVII’s shareholders, to the extent then
known, in the tender offer or proxy solicitation materials, as applicable, furnished to HVII’s shareholders. It is unlikely the
amount of such compensation will be known at the time of distribution of such tender offer materials or at the time of a general meeting
held to consider HVII’s initial business combination, as applicable, as it will be up to the directors of the post-combination
business to determine executive officer and director compensation.
HVII
has entered into a registration rights agreement with respect to the founder shares, private placement units, private placement units
that may be issued upon conversion of working capital loans (and any Class A ordinary shares underlying the private placement units and
any Class A ordinary shares issuable upon conversion of the founder shares).
Related
Party Transactions Policy
HVII
has not yet adopted a formal policy for the review, approval or ratification of related party transactions. Accordingly, the transactions
discussed above were not reviewed, approved or ratified in accordance with any such policy.
88
HVII
has adopted a Code of Ethics requiring it to avoid, wherever possible, all conflicts of interests, except under guidelines or resolutions
approved by HVII’s board of directors (or the appropriate committee of its board) or as disclosed in its public filings with the
SEC. Under HVII’s Code of Ethics, conflict of interest situations will include any financial transaction, arrangement or relationship
(including any indebtedness or guarantee of indebtedness) involving the company.
In
addition, HVII’s audit committee, pursuant to a written charter that HVII adopted prior to the consummation of its initial public
offering, is responsible for reviewing and approving related party transactions to the extent that HVII enters into such transactions.
An affirmative vote of a majority of the members of the audit committee present at a meeting at which a quorum is present will be required
in order to approve a related party transaction. A majority of the members of the entire audit committee will constitute a quorum. Without
a meeting, the unanimous written consent of all of the members of the audit committee will be required to approve a related party transaction.
HVII’s audit committee reviews on a quarterly basis all payments that were made by HVII to its sponsor, officers or directors,
or HVII’s or any of their affiliates.
These
procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a
conflict of interest on the part of a director, officer or service provider.
To
further minimize conflicts of interest, HVII has agreed not to consummate an initial business combination with an entity that is affiliated
with any of HVII’s sponsor, officers or directors unless HVII, or a committee of independent and disinterested directors, have
obtained an opinion from an independent investment banking firm which is a member of FINRA or an independent registered public accounting
firm that HVII’s initial business combination is fair to the company from a financial point of view.
HVII
is not prohibited from paying any fees (including advisory fees), reimbursements or cash payments to its sponsor, officers or directors,
or HVII’s or their affiliates, for services rendered to HVII prior to or in connection with the completion of its initial business
combination, including the following payments, all of which, if made prior to the completion of HVII’s initial business combination,
will be paid from funds held outside the trust account:
●
repayment
of an aggregate of up to $250,000 in loans made to HVII by its sponsor to cover offering-related and organizational expenses;
●
payment
to an affiliate of HVII’s sponsor for office space, utilities and secretarial and administrative support, in an amount equal
to $15,000 per month;
●
payment
of a finder’s fee, advisory fee, consulting fee or success fee for any services they render in order to effectuate the completion
of HVII’s initial business combination;
●
reimbursement
for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination;
●
repayment
of loans which may be made by HVII’s sponsor, an affiliate of its sponsor or its officers and directors to finance transaction
costs in connection with an initial business combination, the terms of which have not been determined nor have any written agreements
been executed with respect thereto. Up to $2.5 million of such loans may be convertible into private placement units of the post-business
combination entity at a price of $10.00 per private placement unit at the option of the lender; and
●
payment
of $10,000 per month until the earlier of the consummation of HVII’s initial business combination or its liquidation to HVII’s
Chief Financial Officer.
These
payments may be made using funds that are not held in the trust account or, upon completion of the initial business combination, from
any amounts remaining from the proceeds of the trust account released to HVII in connection therewith.
89
Director
Independence
Nasdaq
listing standards require that a majority of HVII’s board of directors be independent. An “independent director” is
defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship
which, in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment
in carrying out the responsibilities of a director. As of the date of this Report, HVII has determined that directors Mr. Allen, Mr.
Bonner, Ms. Brunelle, Mr. Saade and Ms. Sharma are “independent directors” as defined in Nasdaq listing standards and applicable
SEC rules. The audit committee of HVII is entirely composed of independent directors meeting Nasdaq’s additional requirements applicable
to members of the audit committee. The independent directors of HVII have regularly scheduled meetings at which only independent directors
are present.
Item
14 . Principal Accountant Fees and Services.
The
firm of WithumSmith+Brown, PC, or Withum, acts as HVII’s independent registered public accounting firm. The following is a summary
of fees paid to Withum for services rendered.
Audit
Fees . During the period from September 27, 2024 (inception) through December 31, 2024, fees for HVII’s independent registered
public accounting firm were approximately $87,300 for the services Withum performed in connection with HVII’s initial public offering
and the audit of HVII’s December 31, 2024 financial statements included in this Report on Form 10-K.
Audit-Related
Fees . During the period from September 27, 2024 (inception) through December 31, 2024, HVII’s independent registered public
accounting firm did not render assurance and related services related to the performance of the audit or review of financial statements.
Tax
Fees . During the period from September 27, 2024 (inception) through December 31, 2024, HVII’s independent registered public
accounting firm did not render services to HVII for tax compliance, tax advice and tax planning.
All
Other Fees . During the period from September 27, 2024 (inception) through December 31, 2024, there were no fees billed for products
and services provided by HVII’s independent registered public accounting firm other than those set forth above.
Pre-Approval
Policy
HVII’s
audit committee was formed upon the consummation of its initial public offering. As a result, the audit committee did not pre-approve
all of the foregoing services, although any services rendered prior to the formation of the audit committee were approved by HVII’s
board of directors. Since the formation of the audit committee, and on a going-forward basis, the audit committee has and will pre-approve
all auditing services and permitted non-audit services to be performed for HVII by its auditors, including the fees and terms thereof
(subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit committee
prior to the completion of the audit).
90
PART
IV
Item
15. Exhibits, Financial Statement Schedules.
(a)
The
following documents are filed as part of this Report:
(1)
Financial
Statements
See
Index to Financial Statements, which appears on page F-1 below. The financial statements listed in the accompanying Index to Financial
Statements are filed herewith in response to this Item.
(2)
Financial
Statements Schedule
None.
(3)
Exhibits
HVII
hereby files as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference
can be inspected and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Room 1580, Washington, D.C.
20549. Copies of such material can also be obtained from the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C.
20549, at prescribed rates or on the SEC website at www.sec.gov.
EXHIBIT
INDEX
Exhibit
No.
Description
1.1
Underwriting Agreement, dated January 16, 2025, by and between Hennessy Capital Investment Corp. VII and Cohen & Company Capital Markets, a Division of J.V.B. Financial Group, LLC, as representative of the underwriters (incorporated by reference to Exhibit 1.1 to Hennessy Capital Investment Corp. VII’s Form 8-K, filed with the SEC on January 21, 2025).
3.1
Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to Hennessy Capital Investment Corp. VII’s Registration Statement on Form S-1 (File No. 333-283087) filed with the SEC on January 15, 2025).
3.2
Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to Hennessy Capital Investment Corp. VII’s Form 8-K, filed with the SEC on January 21, 2025).
4.1
Share Rights Agreement, dated January 16, 2025, by and between Hennessy Capital Investment Corp. VII and Odyssey Transfer and Trust Company (incorporated by reference to Exhibit 4.1 to Hennessy Capital Investment Corp. VII’s Form 8-K, filed with the SEC on January 21, 2025).
4.2*
Description of Securities.
10.1
Letter Agreement, dated January 16, 2025, by and among Hennessy Capital Investment Corp. VII, its officers, its directors and HC VII Sponsor LLC (incorporated by reference to Exhibit 10.1 to Hennessy Capital Investment Corp. VII’s Form 8-K filed with the SEC on January 21, 2025).
10.2
Investment Management Trust Agreement, dated January 16, 2025, by and between Hennessy Capital Investment Corp. VII and Odyssey Transfer and Trust Company, as trustee (incorporated by reference to Exhibit 10.2 to Hennessy Capital Investment Corp. VII’s Form 8-K, filed with the SEC on January 21, 2025).
10.3
Registration Rights Agreement, dated January 16, 2025, by and among Hennessy Capital Investment Corp. VII, HC VII Sponsor LLC, Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, Loop Capital Markets LLC, Clear Street LLC and certain other security holders (incorporated by reference to Exhibit 10.3 to Hennessy Capital Investment Corp. VII’s Form 8-K, filed with the SEC on January 21, 2025).
10.4
Administrative Support Agreement, dated January 16, 2025, by and between Hennessy Capital Investment Corp. VII and HC VII Sponsor LLC (incorporated by reference to Exhibit 10.4 to Hennessy Capital Investment Corp. VII’s Form 8-K, filed with the SEC on January 21, 2025).
10.5
Amended and Restated Founder Shares Subscription Agreement, by and between Hennessy Capital Investment Corp. VII and HC VII Sponsor LLC (incorporated by reference to Exhibit 10.5 to Hennessy Capital Investment Corp. VII’s Registration Statement on Form S-1 (File No. 333-283087) filed with the SEC on January 15, 2025).
10.6
Private Placement Units Purchase Agreement, dated January 16, 2025, by and between Hennessy Capital Investment Corp. VII and HC VII Sponsor LLC (incorporated by reference to Exhibit 10.5 to Hennessy Capital Investment Corp. VII’s Form 8-K, filed with the SEC on January 21, 2025).
10.7
Private Placement Units Purchase Agreement, dated January 16, 2025, by and among Hennessy Capital Investment Corp. VII, Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, Loop Capital Markets LLC and Clear Street LLC (incorporated by reference to Exhibit 10.6 to Hennessy Capital Investment Corp. VII’s Form 8-K, filed with the SEC on January 21, 2025).
91
10.8
Form of Indemnity Agreement, dated January 16, 2025, by and between Hennessy Capital Investment Corp. VII and each of the officers and directors of Hennessy Capital Investment Corp. VII (incorporated by reference to Exhibit 10.7 to Hennessy Capital Investment Corp. VII’s Form 8-K, filed with the SEC on January 21, 2025).
14.1
Form of Code of Conduct and Ethics (incorporated by reference to Exhibit 14.1 to Hennessy Capital Investment Corp. VII’s Registration Statement on Form S-1 (File No. 333-283087) filed with the SEC on January 15, 2025).
19.1*
Insider Trading Policy.
31.1*
Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
31.2*
Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
32.1**
Certification Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002 .
32.2**
Certification Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002 .
97.1*
Policy on Recoupment of Incentive Compensation, dated as of March 28, 2025.
101.INS*
Inline
XBRL Instance Document.
101.SCH*
Inline
XBRL Taxonomy Extension Schema.
101.CAL*
Inline
XBRL Taxonomy Calculation Linkbase.
101.LAB*
Inline
XBRL Taxonomy Label Document.
101.PRE*
Inline
XBRL Definition Linkbase Document.
101.DEF*
Inline
XBRL Definition Linkbase Document.
104*
Cover
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*
Filed
herewith
**
Furnished
herewith
Item
16. Form 10-K Summary.
Not
applicable.
92
HENNESSY
CAPITAL INVESTMENT CORP. VII
INDEX
TO FINANCIAL STATEMENTS
Financial
Statements of Hennessy Capital Investment Corp. VII:
Page
Report
of Independent Registered Public Accounting Firm
F-2
Balance
Sheet as of December 31, 2024
F-3
Statement
of Operations for the Period from September 27, 2024 (Inception) through December 31, 2024
F-4
Statement
of Changes in Shareholders’ Deficit for the Period from September 27, 2024 (Inception) through December 31, 2024
F-5
Statement
of Cash Flows for the Period from September 27, 2024 (Inception) through December 31, 2024
F-6
Notes
to Financial Statements
F-7
to F-17
F- 1
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the Shareholders and the Board of Directors of
Hennessy
Capital Investment Corp. VII
Opinion
on the Financial Statements
We
have audited the accompanying balance sheet of Hennessy Capital Investment Corp. VII (the “Company”) as of December 31, 2024
and the related statements of operations, changes in shareholders’ deficit and cash flows for the period from September 27, 2024
(inception) through December 31, 2024 and the related notes (collectively referred to as the “financial statements”). In
our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2024, and the results of its operations and its cash flows for the period from September 27, 2024 (inception) through December 31,
2024, in conformity with accounting principles generally accepted in the United States of America.
Basis
for Opinion
These
financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (the “PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S.
federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.
/s/
WithumSmith+Brown, PC
We
have served as the Company’s auditor since 2024.
New
York, New York
March
31, 2025
PCAOB
Number 100
F- 2
HENNESSY
CAPITAL INVESTMENT CORP. VII
BALANCE
SHEET
DECEMBER
31, 2024
Assets
Current
assets
Cash
$ 20,005
Prepaid
expenses
20,829
Total
current assets
40,834
Deferred
offering costs
952,432
Total
Assets
$ 993,266
Liabilities
and Shareholders’ Deficit
Current
liabilities
Accrued
expenses
$ 33,366
Accrued
offering costs
456,062
Promissory
note – related party
76,790
Total
current liabilities
566,218
Deferred
legal fees
450,000
Total
Liabilities
1,016,218
Commitments
and Contingencies
Shareholders’
Deficit
Preference
shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
—
Class
A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no shares issued or outstanding
—
Class
B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 6,708,333 shares issued and outstanding (1)(2)
671
Additional
paid-in capital
24,329
Accumulated
deficit
(47,952 )
Total
Shareholders’ Deficit
(22,952 )
Total
Liabilities and Shareholders’ Deficit
$ 993,266
(1)
Includes
up to 875,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the
Underwriters (Note 5).
(2)
On
January 10, 2025, the Company issued an additional 958,333 founder shares for no additional consideration, resulting in the Sponsor
holding a total of 6,708,333 founder shares (see Note 9). All share and per share data has been retrospectively presented.
The
accompanying notes are an integral part of the financial statements.
F- 3
HENNESSY
CAPITAL INVESTMENT CORP. VII
STATEMENT
OF OPERATIONS
FOR
THE PERIOD FROM SEPTEMBER 27, 2024 (INCEPTION) THROUGH DECEMBER 31, 2024
Formation,
general and administrative costs
$ 47,952
Net
loss
$ (47,952 )
Basic
and diluted weighted average Class B ordinary shares outstanding (1)(2)
5,833,333
Basic
and diluted net loss per Class B ordinary share
$ (0.01 )
(1)
Excludes
up to 875,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the
Underwriters (Note 5).
(2)
On
January 10, 2025, the Company issued an additional 958,333 founder shares for no additional consideration, resulting in the Sponsor
holding a total of 6,708,333 founder shares (see Note 9). All share and per share data has been retrospectively presented.
The
accompanying notes are an integral part of the financial statements.
F- 4
HENNESSY
CAPITAL INVESTMENT CORP. VII
STATEMENT
OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR
THE PERIOD FROM SEPTEMBER 27, 2024 (INCEPTION) THROUGH DECEMBER 31, 2024
Class B
Ordinary Shares
Additional Paid-in
Accumulated
Total Shareholders’
Shares
Amount
Capital
Deficit
Deficit
Balance as of September 27, 2024 (inception)
—
$ —
$ —
$ —
$ —
Class B ordinary shares issued to Sponsor (1)(2)
6,708,333
671
24,329
—
25,000
Net loss
—
—
—
(47,952 )
(47,952 )
Balance as of December 31, 2024
6,708,333
$ 671
$ 24,329
$ (47,952 )
$ (22,952 )
(1)
Includes
up to 875,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the
Underwriters (Note 5).
(2)
On
January 10, 2025, the Company issued an additional 958,333 founder shares for no additional consideration, resulting in the Sponsor
holding a total of 6,708,333 founder shares (see Note 9). All share and per share data has been retrospectively presented.
The
accompanying notes are an integral part of the financial statements.
F- 5
HENNESSY
CAPITAL INVESTMENT CORP. VII
STATEMENT
OF CASH FLOWS
FOR
THE PERIOD FROM SEPTEMBER 27, 2024 (INCEPTION) THROUGH DECEMBER 31, 2024
Cash
flows from operating activities:
Net
loss
$ (47,952 )
Adjustments
to reconcile net loss to net cash used in operating activities:
Changes
in operating assets and liabilities:
Prepaid
expenses
(20,829 )
Accrued
expenses
33,366
Net
cash used in operating activities
(35,415 )
Cash
flows from financing activities:
Proceeds
from issuance of founder shares
25,000
Proceeds
from promissory note – related party
76,790
Payment
of deferred offering costs
(46,370 )
Net
cash provided by financing activities
55,420
Net
change in cash
20,005
Cash,
beginning of the period
—
Cash,
end of the period
$ 20,005
Noncash
investing and financing activities:
Deferred
offering costs included in accrued offering costs
$ 456,062
Deferred
offering costs included in deferred legal fees
$ 450,000
The
accompanying notes are an integral part of the financial statements.
F- 6
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
NOTE
1 — ORGANIZATION AND BUSINESS OPERATIONS
Hennessy
Capital Investment Corp. VII (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on
September 27, 2024. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization, or similar business combination with one or more businesses (the “Business Combination”). As of December
31, 2024, the Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf,
engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to an initial Business
Combination with the Company.
As
of December 31, 2024, the Company had not commenced any operations. All activity for the period from September 27, 2024 (inception) through
December 31, 2024 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”),
as described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income on investments from the proceeds derived
from the Initial Public Offering.
The
registration statement for the Company’s Initial Public Offering was declared effective on January 16, 2025. On January 21, 2025,
the Company consummated the Initial Public Offering of 19,000,000 units (the “Units”), which includes the partial exercise
by the underwriters of their over-allotment option in the amount of 1,500,000 Units, at $10.00 per Unit, generating gross proceeds of
$190,000,000, which is described in Note 3. Each Unit consists of one Class A ordinary share and one right to receive one-twelfth (1/12)
of one Class A ordinary share upon the consummation of an initial Business Combination (“Share Right”).
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 690,000 private placement units
(the “Private Placement Units”) at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,900,000,
which is described in Note 4. Of the 690,000 Private Placement Units, 500,000 Private Placement Units were purchased by HC VII Sponsor
LLC, the Company’s sponsor (the “Sponsor”), and an aggregate of 190,000 Private Placement Units were purchased by the
underwriters of the Initial Public Offering (collectively, the “Underwriters”): Cohen & Company Capital Markets, a division
of J.V.B Financial Group, LLC (133,000); Clear Street LLC (28,500); and Loop Capital Markets LLC (28,500). The Private Placement Units
are identical to the Units sold in the Initial Public Offering, except that (i) the Private Placement Units (and the Class A ordinary
shares and Share Rights underlying the Private Placement Units and the Class A ordinary shares issuable upon conversion of the Share
Rights) may not be transferred, assigned or sold, subject to certain limited exceptions, until 30 days after the completion of the initial
Business Combination and (ii) the holders of the Private Placement Units are entitled to certain registration rights in respect thereof
(and with respect to the Class A ordinary shares and Share Rights underlying such Private Placement Units and the Class A ordinary shares
issuable upon conversion of the Share Rights).
Transaction
costs amounted to $12,656,782, consisting of $3,800,000 of cash underwriting fee, $7,600,000 of deferred underwriting fee and $1,256,782
of other offering costs.
The
Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the Private Placement Units, although substantially all of the net proceeds are intended to be generally applied toward consummating
a Business Combination (less deferred underwriting commissions).
The
Company’s Business Combination must be with one or more target businesses that together have a fair market value equal to at least
80% of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and taxes
payable on the income earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However,
the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no
assurance that the Company will be able to successfully effect a Business Combination.
F- 7
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
Following
the closing of the Initial Public Offering on January 21, 2025, an amount of $190,000,000 ($10.00 per Unit) from the net proceeds of
the sale of the Units, and a portion of the net proceeds from the sale of the Private Placement Units, was placed in the trust account
(“Trust Account”), located in the United States, with Odyssey Transfer and Trust Company acting as trustee. The funds will
be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain
conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations, and/or
(ii) deposited in an interest-bearing demand deposit account at a U.S.-chartered commercial bank with consolidated assets of $50 billion
or more. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act,
which risk increases the longer that the Company holds investments in the Trust Account, the Company may, at any time (based on the management
team’s ongoing assessment of all factors related to the Company’s potential status under the Investment Company Act), instruct
the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an
interest bearing account until the earlier of consummation of the initial Business Combination or liquidation of the Company. Except
with respect to interest earned on the funds held in the Trust Account that may be released to the Company to fund its working capital
requirements, subject to an annual limit of 5.0%, and to pay its taxes, other than excise taxes, if any, (“permitted withdrawals”)
and up to $100,000 of interest to pay dissolution expenses, the proceeds from the Initial Public Offering and the sale of the Private
Placement Units will not be released from the Trust Account until the earliest of (i) the completion of the Company’s initial Business
Combination, (ii) the redemption of the Company’s Class A ordinary shares sold as part of the Units in the Initial Public Offering
(the “public shares”) if the Company is unable to complete the initial Business Combination within 24 months from the closing
of the Initial Public Offering or by such earlier liquidation date as the Company’s board of directors may approve (the “Completion
Window”), subject to applicable law, or (iii) the redemption of the Company’s public shares properly submitted in connection
with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance
or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100%
of the Company’s public shares if the Company has not consummated an initial Business Combination within the Completion Window
or (B) with respect to any other provisions relating to shareholders’ rights or pre-initial Business Combination activity. The
proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have
priority over the claims of the Company’s public shareholders.
The
Company will provide the Company’s public shareholders with the opportunity to redeem all or a portion of their public shares upon
the completion of the initial Business Combination either in connection with a general meeting called to approve the initial Business
Combination or by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial
Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be
entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account
calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds
held in the Trust Account (less permitted withdrawals), divided by the number of then outstanding public shares, subject to the limitations.
The
ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the
Initial Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification
(“ASC”) Topic 480, “Distinguishing Liabilities from Equity.”
The
Company will have only the duration of the Completion Window to complete the initial Business Combination. However, if the Company is
unable to complete its initial Business Combination within the Completion Window, the Company will as promptly as reasonably possible
but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less the amount of permitted
withdrawals and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which
redemption will constitute full and complete payment for the public shares and completely extinguish public shareholders’ rights
as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the Company’s obligations
under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law.
F- 8
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
The
Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they
have agreed to (i) waive their redemption rights with respect to their Class B ordinary shares of the Company (“founder shares”),
private placement shares and public shares in connection with the completion of the initial Business Combination; (ii) waive their redemption
rights with respect to their founder shares and private placement shares in connection with a shareholder vote to approve an amendment
to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s
obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company
has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions
relating to shareholders’ rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions
from the Trust Account with respect to their founder shares and private placement shares if the Company fails to complete the initial
Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account
with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window
and to liquidating distributions from assets outside the Trust Account; and (iv) vote any founder shares or private placement shares
held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated
transactions, aside from shares they may purchase in compliance with the requirements of Rule 14e-5 under the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), which would not be voted in favor of approving the Business Combination) in favor
of the initial Business Combination.
The
Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services
rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of
intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account
to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date
of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes
payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver
of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims
under the Company’s indemnity of the Underwriters of the Initial Public Offering against certain liabilities, including liabilities
under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve
for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy
its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the
Company cannot assure that the Sponsor would be able to satisfy those obligations.
NOTE
2 — SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(the “U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).
Liquidity
and Capital Resources
The
Company’s liquidity needs up to December 31, 2024 had been satisfied through the loan under an unsecured promissory note from the
Sponsor of up to $250,000 (see Note 5). At December 31, 2024, the Company had cash of $20,005 and working capital deficit of $525,384.
Further, the Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. In connection
with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification 205-40, “Going
Concern,” as of December 31, 2024, and including the closing of the Initial Public Offering on January 21, 2025, the Company has
sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial
statements.
F- 9
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
Use
of Estimates
The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $20,005 in cash and no cash equivalents as of December 31, 2024.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access
to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
F- 10
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
Deferred
Offering Costs
The
Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses
of Offering.” Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering.
FASB ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible
debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds, on January
21, 2025, from the Units between Class A ordinary shares and Share Rights, using the residual method by allocating Initial Public Offering
proceeds first to assigned value of the rights and then to the Class A ordinary shares. Offering costs allocated to the Class A ordinary
shares subject to possible redemption were charged to temporary equity and offering costs allocated to the Share Rights included in the
Public and Private Placement Units were charged to shareholders’ deficit because the Share Rights included in the Public and Private
Placement Units, after management’s evaluation, were accounted for under equity treatment. As of December 31, 2024 the Company
has $952,432 in deferred offering costs as recorded on the accompanying balance sheet.
Fair
Value of Financial Instruments
The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value
Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term
nature.
Income
Taxes
The
Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to
financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between
the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted
tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of
tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely
than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is
the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. As of December 31, 2024, there were no unrecognized tax benefits and no amounts accrued for interest and penalties.
The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation
from its position.
The
Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently
not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s
tax provision was zero for the period presented.
Derivative
Financial Instruments
The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted
for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each
reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net cash settlement or conversion
of the instrument could be required within 12 months of the balance sheet date. The Underwriters’ over-allotment option is deemed
to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant
to ASC 480 if not fully exercised at the time of the Initial Public Offering.
F- 11
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
Share
Rights
The
Company accounted for the Share Rights issued in connection with the Initial Public Offering and the private placement in accordance
with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging.” Accordingly, the Company evaluated and classified
the Share Rights under equity treatment at its assigned value.
Net
Loss Per Ordinary Share
Net
loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period,
excluding ordinary shares subject to forfeiture, through the date of the Initial Public Offering. Weighted average shares were reduced
for the effect of an aggregate of 875,000 ordinary shares that are subject to forfeiture by the holders thereof depending on the extent
to which the Underwriter’s over-allotment option is exercised (see Note 5). At December 31, 2024, the Company did not have any
dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the
earnings of the Company. As a result, diluted loss per ordinary share is the same as basic loss per ordinary share for the periods presented.
Share-Based
Compensation
The
Company records share-based compensation in accordance with FASB ASC Topic 718, “Compensation-Share Compensation” (“ASC
718”), guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee
share option or similar equity instrument. The Company recognizes all forms of share-based payments at their fair value on the grant
date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments are valued using a
Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded
at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line
basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur,
any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation
expenses are included in costs and operating expenses depending on the nature of the services provided in the statement of operations.
Recent
Accounting Standards
In November 2023, the FASB issued ASU 2023-07,
“Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The amendments in this ASU require disclosures,
on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”),
as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that
a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment
profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all
annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to
provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective
for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early
adoption permitted. The Company has adopted ASU 2023-07 at inception, September 27, 2024. ASU 2023-07 does not have a material effect
on the Company’s financial statements.
Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a
material effect on the Company’s financial statements.
NOTE
3 — INITIAL PUBLIC OFFERING
Pursuant
to the Initial Public Offering, on January 21, 2025, the Company sold 19,000,000 Units, which includes the partial exercise by the Underwriters
of their over-allotment option in the amount of 1,500,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class
A ordinary share and one Share Right entitling the holder thereof to receive one-twelfth (1/12) of one Class A ordinary share upon the
consummation of an initial Business Combination.
NOTE
4 — PRIVATE PLACEMENT
Simultaneously
with the closing of the Initial Public Offering, the Sponsor and the Underwriters purchased an aggregate of 690,000 Private Placement
Units, each Private Placement Unit consisting of one Class A ordinary share and one Share Right to receive one-twelfth (1/12) of one
Class A ordinary share upon the consummation of an initial Business Combination, at a price of $10.00 per Private Placement Unit, or
$6,900,000 in the aggregate, in a private placement. Of the 690,000 Private Placement Units, 500,000 Private Placement Units were purchased
by the Sponsor, and an aggregate of 190,000 Private Placement Units were purchased by the Underwriters: Cohen & Company Capital Markets
(133,000); Clear Street LLC (28,500); and Loop Capital Markets LLC (28,500).
F- 12
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
The
Private Placement Units are identical to the Units sold in the Initial Public Offering except that, so long as they are held by the Sponsor,
the Underwriters or their permitted transferees, the Private Placement Units (including their component securities) (i) may not (including
the Class A ordinary shares issuable upon conversion of the underlying Share Rights), subject to certain limited exceptions, be transferred,
assigned or sold by the holders until 30 days after the completion of the initial Business Combination and (ii) will be entitled to certain
registration rights in respect thereof (and with respect to the Class A ordinary shares and Share Rights underlying such Private Placement
Units and the Class A ordinary shares issuable upon conversion of the Share Rights).
The
Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they
have agreed to (i) waive their redemption rights with respect to their founder shares, private placement shares and public shares in
connection with the completion of the initial Business Combination; (ii) waive their redemption rights with respect to their founder
shares and private placement shares in connection with a shareholder vote to approve an amendment to the Company’s amended and
restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption
in connection with the initial Business Combination or to redeem 100% of the public shares if the Company has not consummated an initial
Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’
rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions from the Trust Account with
respect to their founder shares and private placement shares if the Company fails to complete the initial Business Combination within
the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public
shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions
from assets outside the Trust Account; and (iv) vote any founder shares or private placement shares held by them and any public shares
purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions, aside from shares
they may purchase in compliance with the requirements of Rule 14e-5 under the Exchange Act, which would not be voted in favor of approving
the Business Combination) in favor of the initial Business Combination.
NOTE
5 — RELATED PARTY TRANSACTIONS
Founder
Shares
On
October 8, 2024, the Sponsor made a capital contribution of $25,000, or approximately $0.004 per share, for which the Company issued
5,750,000 founder shares to the Sponsor. On January 10, 2025, the Company issued an additional 958,333 founder shares (up to 125,000
shares of which are subject to forfeiture depending on the extent to which the Underwriters’ over-allotment option is exercised)
for no additional consideration, resulting in the Sponsor holding a total of 6,708,333 founder shares (up to 875,000 of which are subject
to forfeiture by the holders thereof depending on the extent to which the Underwriters’ option to purchase additional Units is
exercised). All share and per share data has been retrospectively presented. On January 21, 2025, the Underwriters partially exercised
their over-allotment option and forfeited the unexercised balance. As a result of the partial exercise and the subsequent forfeiture
of the over-allotment option by the Underwriters, 500,000 founder shares are no longer subject to forfeiture and 375,000 founder shares
were forfeited, resulting in the Sponsor (after giving effect to the founder share transfers described below) holding 5,203,333 founder
shares.
On
December 1, 2024 and January 1, 2025, the Sponsor transferred 250,000 and 750,000 founder shares to each of Nicholas Geeza, the Company’s
Executive Vice President, Chief Financial Officer (“CFO”) and Secretary, and Thomas Hennessy, the Company’s President
and Chief Operating Officer (“COO”), respectively. The founder shares were transferred for total consideration of $0.004
per share, or $1,000 and $3,000, respectively, due to the Sponsor. On December 19, 2024, the Sponsor transferred an aggregate of 130,000
founder shares to its independent directors, for total consideration of $0.004 per share, or $520, due to the Sponsor. The founder shares
are automatically forfeited back to the Sponsor if the holder of such founder shares is no longer providing services to the Company prior
to the initial Business Combination. The sale of the founder shares to the Company’s CFO, COO, and its independent directors, are
in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based
compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 1,130,000
shares granted to the Company’s CFO, COO, and its independent directors were $1,118,700 or $0.99 per share. The founder shares
were granted subject to a performance condition (i.e., providing services through the Company’s initial Business Combination).
Compensation expense related to the founder shares is recognized only when the performance condition is probable of occurrence under
the applicable accounting literature in this circumstance.
F- 13
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
The
Company’s initial shareholders have agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary
shares issued upon conversion thereof until the earlier to occur of (i) 180 days after the completion of the Company’s initial
Business Combination or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction
after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class
A ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other
agreements of the Company’s initial shareholders with respect to any founder shares (the “Lock-up”).
Promissory
Note — Related Party
The
Sponsor has agreed to loan the Company an aggregate of up to $250,000 to be used for a portion of the expenses of the Initial Public
Offering (the “Promissory Note”). The Promissory Note is non-interest bearing, unsecured and due at the earlier of March
31, 2025 or the closing of the Initial Public Offering. As of December 31, 2024, the Company had borrowed $76,790 under the Promissory
Note. On January 21, 2025, the Company repaid the total outstanding balance of the Promissory Note amounting to $109,994. Borrowings
under the Promissory Note are no longer available.
Working
Capital Loans
In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of
the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working
Capital Loans”). If the Company completes an initial Business Combination, the Company would repay the Working Capital Loans. In
the event that an initial Business Combination does not close, the Company may use a portion of the working capital held outside the
Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans.
Up to $2,500,000 of such Working Capital Loans may be convertible into Private Placement Units of the post Business Combination entity
at a price of $10.00 per Unit at the option of the lender. As of December 31, 2024, no such Working Capital Loans were outstanding.
Administrative
Services Agreement and Payments to Officer
The
Company entered into an agreement with the Sponsor, commencing on January 17, 2025 through the earlier of the Company’s consummation
of a Business Combination and its liquidation, to pay an aggregate of $15,000 per month for office space, utilities, and secretarial
and administrative support services.
The
Company entered into an agreement with the CFO, commencing on January 17, 2025, to pay an aggregate of $10,000 per month for services
prior to the consummation of the Company’s initial Business Combination or until the Company’s liquidation.
F- 14
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
NOTE
6 — COMMITMENTS AND CONTINGENCIES
Risks
and Uncertainties
The
United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the
ongoing Russia-Ukraine conflict and the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic
Treaty Organization (“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom,
the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals
and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication
(“SWIFT”) payment system. Certain countries, including the United States, have also provided and may continue to provide
military aid or other assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The invasion of
Ukraine by Russia and the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by
NATO, the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global
security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts
are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital
markets, as well as supply chain interruptions and increased cyber-attacks against U.S. companies. Additionally, any resulting sanctions
could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any
of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions
resulting from the Russian invasion of Ukraine, the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely
affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate
an initial Business Combination.
Registration
Rights
The
holders of the founder shares, Private Placement Units and the Class A ordinary shares underlying such Private Placement Units and Share
Rights and any Private Placement Units that may be issued upon conversion of the Working Capital Loans will have registration rights
to require the Company to register a sale of any of the Company’s securities held by them and any other securities of the Company
acquired by them prior to the consummation of the initial Business Combination. The holders of these securities are entitled to make
up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain
piggyback registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination.
The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting
Agreement
The
Underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 2,625,000 Units to cover
over-allotments, if any. On January 21, 2025, the Underwriters partially exercised their over-allotment option in the amount of 1,500,000
Units and forfeited the remaining unexercised balance of 1,125,000 Units.
The
Underwriters were entitled to a cash underwriting discount of $0.20 per Unit, or $3,800,000 in the aggregate, paid to the Underwriters
in cash at the closing of the Initial Public Offering. Additionally, the Underwriters are entitled to a deferred underwriting discount
of up to $0.40 per Unit, or up to $7,600,000 in the aggregate (subject to reduction based on the funds remaining in the Trust Account
after giving effect to the public shares that are redeemed in connection with the Company’s initial Business Combination), payable
to the Underwriters for deferred underwriting commissions on amounts remaining in the Trust Account after all redemptions by public shareholders
have been met. The deferred underwriting discount will become payable to the Underwriters from the amounts held in the Trust Account
solely in the event the Company completes its initial Business Combination.
Deferred
Legal Fees
As
of December 31, 2024, the Company had a total deferred legal fee of $450,000, all of which was related to the Initial Public Offering
to be paid to the Company’s legal advisors upon consummation of the Business Combination. As the settlement or liquidation of amounts
of deferred legal fees are not reasonably expected to require the use of current assets or require the creation of current liabilities,
the amount is classified as a non-current liability in the accompanying balance sheet as of December 31, 2024.
NOTE
7 — SHAREHOLDERS’ DEFICIT
Preference
Shares — The Company is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001 each. As of
December 31, 2024, there were no preference shares issued or outstanding.
F- 15
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
Class
A Ordinary Shares — The Company is authorized to issue a total of 200,000,000 Class A ordinary shares at par value of $0.0001
each. As of December 31, 2024, there were no Class A ordinary shares issued or outstanding.
Class
B Ordinary Shares — The Company is authorized to issue a total of 20,000,000 Class B ordinary shares at par value of $0.0001
each. On October 8, 2024, the Sponsor made a capital contribution of $25,000, or approximately $0.004 per share, for which the Company
issued 5,750,000 founder shares to the Sponsor. On January 10, 2025, the Company issued an additional 958,333 founder shares (up to 125,000
shares of which are subject to forfeiture depending on the extent to which the Underwriters’ over-allotment option is exercised)
for no additional consideration, resulting in the Sponsor holding a total of 6,708,333 founder shares (up to 875,000 of which are subject
to forfeiture by the holders thereof depending on the extent to which the Underwriters’ option to purchase additional units is
exercised).
The
founder shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of
the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the
case that additional Class A ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts
sold in the Initial Public Offering and related to or in connection with the closing of the initial Business Combination, the ratio at
which Class B ordinary shares convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding
Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class
A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 25% of the sum of (i) the total
number of all Class A ordinary shares outstanding upon the completion of the Initial Public Offering (including any Class A ordinary
shares issued pursuant to the Underwriters’ over-allotment option and excluding the Class A ordinary shares underlying the Private
Placement Units issued to the Sponsor and the Underwriters), plus (ii) all Class A ordinary shares and equity-linked securities issued
or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities
issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent shares issued to the
Sponsor or any of its affiliates or to the Company’s officers or directors upon conversion of Working Capital Loans) minus (iii)
any redemptions of Class A ordinary shares by public shareholders in connection with an initial Business Combination; provided that such
conversion of founder shares will never occur on a less than one-for-one basis.
Holders
of record of the Company’s Class A ordinary shares and Class B ordinary shares are entitled to one vote for each share held on
all matters to be voted on by shareholders. Unless specified in the amended and restated memorandum and articles of association or as
required by the Companies Act or stock exchange rules, an ordinary resolution under Cayman Islands law and the amended and restated memorandum
and articles of association, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being
entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the company is generally
required to approve any matter voted on by the Company’s shareholders. Approval of certain actions require a special resolution
under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by
such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting,
and pursuant to the Company’s amended and restated memorandum and articles of association, such actions include amending the amended
and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. There is
no cumulative voting with respect to the appointment of directors, meaning, following the Company’s initial Business Combination,
the holders of more than 50% of the ordinary shares voted for the appointment of directors can elect all of the directors. Prior to the
consummation of the initial Business Combination, only holders of the Class B ordinary shares will (i) have the right to vote on the
appointment and removal of directors and (ii) be entitled to vote on continuing the Company in a jurisdiction outside the Cayman Islands
(including any special resolution required to amend the constitutional documents or to adopt new constitutional documents, in each case,
as a result of approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of the Class A ordinary
shares will not be entitled to vote on these matters during such time. These provisions of the amended and restated memorandum and articles
of association may only be amended if approved by a special resolution passed by the affirmative vote of at least 90% (or, where such
amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes cast by such shareholders
as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company.
Share
Rights — Except in cases where the Company is not the surviving company in a Business Combination, each holder of a Share
Right will automatically receive one-twelfth (1/12) of one Class A ordinary share upon consummation of the initial Business Combination.
The Company will not issue fractional shares in connection with an exchange of Share Rights. Fractional shares will either be rounded
down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company
is not the surviving company upon completion of the initial Business Combination, each holder of a Share Right will be required to affirmatively
convert his, her or its Share Rights in order to receive the one-twelfth (1/12) of one Class A ordinary share underlying each Share Right
upon consummation of the Business Combination. If the Company is unable to complete the initial Business Combination within the required
time period and the Company will redeem the public shares for the funds held in the Trust Account, holders of Share Rights will not receive
any of such funds for their Share Rights and the Share Rights will expire worthless.
F- 16
HENNESSY
CAPITAL INVESTMENT CORP. VII
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2024
NOTE
8 — SEGMENT REPORTING
ASC
Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about
operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise
that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information
is available that is regularly evaluated by the Company’s CODM, or group, in deciding how to allocate resources and assess performance.
The
Company’s CODM has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics
for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management
has determined that there is only one reportable segment.
The
CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported
on the statement of operations as net income or loss. The measure of segment assets is reported on the balance sheet as total
assets. When evaluating the Company’s performance and making key decisions regarding
resource allocation, the CODM reviews the below key metric included in net income or loss:
For the
period from
September
27,
2024 (inception)
through
December 31, 2024
Formation, general and administrative costs
$ 47,952
Formation,
general and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available
to complete a Business Combination or similar transaction within the Completion Window. The CODM also reviews formation, general and
administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.
Formation, general and administrative costs, as reported on the statement of operations, are the significant segment expenses provided
to the CODM on a regular basis.
All
other segment items included in net income or loss are reported on the statement of operations and described within their respective
disclosures.
NOTE
9 — SUBSEQUENT EVENTS
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Other than as described below and in these financial statements, the Company did not identify any subsequent events that
would have required adjustment or disclosure in the financial statements.
On
January 10, 2025, the Company issued an additional 958,333 founder shares (up to 125,000 shares of which are subject to forfeiture depending
on the extent to which the Underwriters’ over-allotment option is exercised) for no additional consideration, resulting in the
Sponsor holding a total of 6,708,333 founder shares (up to 875,000 of which are subject to forfeiture by the holders thereof depending
on the extent to which the Underwriters’ option to purchase additional units is exercised).
On
January 21, 2025, the Company consummated the Initial Public Offering of 19,000,000 Units, which includes the partial exercise by the
Underwriters of their over-allotment option in the amount of 1,500,000 Units, at $10.00 per Unit, generating gross proceeds of $190,000,000.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 690,000 Private Placement
Units at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,900,000. Of the 690,000 Private Placement Units,
500,000 Private Placement Units were purchased by the Sponsor, and an aggregate of 190,000 Private Placement Units were purchased by
the Underwriters: Cohen & Company Capital Markets (133,000); Clear Street LLC (28,500); and Loop Capital Markets LLC (28,500).
On
January 21, 2025, in connection with the closing of the Initial Public Offering, the Underwriters were paid a cash underwriting discount
of $0.20 per Unit, or $3,800,000 in the aggregate. Additionally, the Underwriters are entitled to a deferred underwriting discount of
up to $0.40 per Unit, or up to $7,600,000 in the aggregate (subject to reduction based on the funds remaining in the Trust Account after
giving effect to the public shares that are redeemed in connection with an initial Business Combination), payable to the Underwriters
for deferred underwriting commissions on amounts remaining in the Trust Account after all redemptions by public shareholders have been
met.
On
January 21, 2025, the Company repaid all outstanding amounts under the Promissory Note.
F- 17
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the Registrant has duly caused this Annual Report to be signed
on its behalf by the undersigned, thereunto duly authorized.
Date:
March 31, 2025
HENNESSY
CAPITAL INVESTMENT CORP. VII
By:
/ s/
Daniel J. Hennessy
Name:
Daniel
J. Hennessy
Title:
Chairman
of the Board of Directors and
Chief
Executive Officer
( Principal
Executive Officer )
Pursuant
to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf
of the registrant and in the capacities and on the dates indicated.
Name
Position
Date
/s/
Daniel J. Hennessy
Chairman
of the Board of Directors and Chief Executive Officer
March
31, 2025
Daniel
J. Hennessy
(Principal
Executive Officer )
/s/ Thomas D. Hennessy
President and Chief Operating Officer and
March 31, 2025
Thomas D. Hennessy
Director
/s/ Nicholas Geeza
Executive
Vice President, Chief Financial Officer and Secretary
March
31, 2025
Nicholas
Geeza
( Principal
Financial and Accounting Officer )
/s/
Grant R. Allen
Director
March
31, 2025
Grant
R. Allen
/s/
Brian Bonner
Director
March
31, 2025
Brian
Bonner
/s/
Anna Brunelle
Director
March
31, 2025
Anna
Brunelle
/s/
Javier Saade
Director
March
31, 2025
Javier
Saade
/s/
Poonam Sharma
Director
March
31, 2025
Poonam
Sharma
93
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.